NCT03234205

Brief Summary

Measurement of T2 transversal relaxation time by magnetic resonance has a major interest in cardiac imagery. It has been initially used for quantitative evaluation of heart viability and more recently for edema characterization. It allows to prematurely detect a cardiac transplant rejection. This technique needs successively around ten FSE sequences during apnea. Weak reproducibility of successive apneas and discomfort of patient limit the precision of this measurement and consequently its use in standard care. The ARTEMIS study method allows the examination during free respiration without prolonging the duration of examination compared to the examination during apnea. Moreover, image processing is simplified and correction of respiratory movements renders results more reliable. This is a pilot study of evaluation of ARTEMIS technique of image reconstruction. ARTEMIS is a method of MRI image reconstruction for measurements of T2 transversal relaxation. It allows to obtain diagnostic images without movement artifacts. The primary objective si to show the feasibility of ARTEMIS method for measurement of myocardial T2 relaxation time during free respiration in cardiac transplant patients. The secondary objective is to collect quantitative data to compare ARTEMIS method of measurement of T2 during free respiration and standard clinical practice during apnea.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 31, 2011

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2012

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

July 26, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 31, 2017

Completed
Last Updated

August 3, 2017

Status Verified

July 1, 2017

Enrollment Period

1.3 years

First QC Date

July 26, 2017

Last Update Submit

August 2, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Image quality assessed y senior radiologists

    baseline

  • Movement correction in images assessed by senior radiologists

    baseline

Secondary Outcomes (1)

  • Quantitative measurement of myocardial transversal relaxation time in 6 segments of short median axe cross-section of left ventricle in standard and ARTEMIS images

    baseline

Study Arms (1)

MRI scan during free respiration

EXPERIMENTAL
Device: MRI scan

Interventions

MRI scanDEVICE

MRI standard protocol with addition of: * a second clinical respiratory belt besides belt usually installed for clinical examination * a second clinical electrocardiogram sensor besides sensor usually installed for clinical examination * 12 sequences during free respiration are added lasting supplementary 15 minutes * Use of cardiac antennae usually used for cardiac MRI scans

MRI scan during free respiration

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • To have had a heart transplant, whenever
  • To have an MRI scan of heart with measurement of T2 relaxation time (whatever the reason for examination)
  • Major
  • To be aware and cooperative
  • Affiliation to social security plan
  • To have given written consent after having received oral and written, clear and intelligible information

You may not qualify if:

  • All contraindications to MRI (implantable defibrillator, cochlear implant, neurosurgical clip, intraorbital or encephalic metallic foreign body, endoprosthesis installed since less than 4 weeks, osteosynthesis materials installed since less than 6 weeks…)
  • Instable hemodynamic status, acute respiratory failure, uncertain general status or necessity of continuous monitoring incompatible with MRI examination
  • Minors or being under juridical protection or absence of social security
  • Refusal or impossibility of informed consent of patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Nancy Brabois

Vandœuvre-lès-Nancy, France

Location

MeSH Terms

Interventions

Magnetic Resonance Imaging

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2017

First Posted

July 31, 2017

Study Start

August 31, 2011

Primary Completion

December 19, 2012

Study Completion

December 19, 2012

Last Updated

August 3, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations